Chronic myeloid leukemia today: 16 years of observation
Автор: Lyamkina A. S., Maslova L. M., Naumenko O. V., Melnichenko E. V., Obgolts Y. N., Loginova A. B., Daragan E. V., Nechunaeva I. N., Vorontsova E. V., Shpagina L. A., Yudanov A. V., Khalzov K. V., Pospelova T. I.
Журнал: Вестник гематологии @bulletin-of-hematology
Рубрика: Оригинальные статьи
Статья в выпуске: 3 т.16, 2020 года.
Бесплатный доступ
The incidence of chronic myeloid leukemia from 2004 to 2020 amounted to 0.64 per 100000 people per year. The prevalence of chronic myeloid leukemia over the past 16 years has increased from 1,88 to 7.43 case per 100000 people. We have analyzed the therapy outcomes of chronic myeloid leukemia of patients, received imatinib treatment for more than 12 months (204 patients). Complete hematologic response (CHO) is attained in 90,2% cases (184 patients), complete cytogenetic response (CCR) (Рh+
Chronic myeloid leukemia, epidemiology, complete cytogenetic response, major molecular response, survival
Короткий адрес: https://sciup.org/170172546
IDR: 170172546
